> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Quelicin Not Withdrawn Due to Safety/Efficacy
- URL: https://www.fdaweb.com/quelicin-not-withdrawn-due-to-safety-efficacy/
- Published: 2021-06-07T12:00:00.000Z
- Updated: 2026-09-14T17:02:06.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5149476

*Federal Register* notice: FDA has determined that Hospira’s Quelicin Preservative Free (succinylcholine chloride) injection, 20mg/mL, 50mg/mL and 100mg/mL, was not withdrawn due to safety or effectiveness reasons. The determination will allow FDA to approve ANDAs that reference the product if all other legal and regulatory requirements are met. The drug is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2021-06-07/pdf/2021-11802.pdf?ref=fdaweb.com).